Concepedia

Author

Yurday Özdemir

Başkent UniversityORCID

Also Known As

Eyüb Yaşar Akdemir, Hatice Coşkun, Ozdemir,Yurday, Sercan Kiremitçi, Y Ozdemir, Y. Ozdemir, YURDAY OZDEMIR, Yalçın Özdemir, Yasemin Ceyhan Ozdemir, Yurday OZDEMIR

58

Publications

414

Citations

12

H-Index

16

Concepts

All Affiliations

Başkent UniversityThe University of Texas MD Anderson Cancer CenterKoç UniversityMersin ÜniversitesiBahçeşehir University
YÖ

About

Yurday Özdemir is an author at Başkent University specializing in oncology, radiation oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

108

2

Health Sciences

3

3

58

3

Cancer Therapeutics

3

3

61

4

Gastroenterology

1

1

17

5

Neurology

1

1

29

Yurday Özdemir

×

14

Publications

328

Citations

12

H-Index

YearCitations

<p>Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy</p>

Erkan Topkan, Hüseyin Mertsoylu, Yurday Özdemir,

Cancer Management and Research

2019

44

Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol

Erkan Topkan, Ahmet Küçük, Yurday Özdemir,

Journal of Immunology Research

2020

41

Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases

Yurday Özdemir, Neşe Torun, Ozan Cem Güler,

Journal of bone oncology

2019

33

Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors

Yurday Özdemir, Berna Akkuş Yıldırım, Erkan Topkan

Journal of Neuro-Oncology

2016

30

Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide

Erkan Topkan, Uğur Selek, Yurday Özdemir,

Journal of Neuro-Oncology

2018

29

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

Erkan Topkan, Ali Ayberk Beşen, Yurday Özdemir,

Mediators of Inflammation

2020

23

Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer

Erkan Topkan, Uğur Selek, Yurday Özdemir,

Lung Cancer

2018

21

<p>Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy</p>

Yurday Özdemir, Erkan Topkan, Hüseyin Mertsoylu,

Cancer Management and Research

2020

21

Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapy

Berna Akkuş Yıldırım, Yurday Özdemir, Tamer Çolakoğlu,

Pancreatology

2016

17

Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy

Erkan Topkan, Nur Yücel Ekici, Yurday Özdemir,

The International Journal of Biological Markers

2019

17

Page 1